安必平: 第四届监事会第九次会议决议公告

Meeting Overview - The fourth session of the Supervisory Board of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. was held on August 21, 2025, combining in-person and remote participation [1] - The meeting was convened by Chairwoman Jin Xinyu, with all three supervisors participating in the voting [1] Resolutions Passed - The Supervisory Board approved the "2025 Half-Year Report" and its summary, confirming that the report accurately reflects the company's financial status and operational results for the reporting period [1][2] - The board also approved the "Special Report on the Storage and Actual Use of Raised Funds for the First Half of 2025," which disclosed the management of raised funds without any misappropriation or harm to shareholder interests [2] - Approval was granted for the use of up to 140 million yuan of temporarily idle raised funds for cash management, ensuring compliance with relevant regulations and not affecting the normal implementation of investment projects [3] - The board agreed to temporarily adjust the use of idle spaces from fundraising investment projects for external leasing, which aligns with the company's operational stability [4]